BRPI0715893A2 - composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono - Google Patents

composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono

Info

Publication number: BRPI0715893A2
Authority: BR; Brazil
Prior art keywords: dysthymic; medicament; prevention; preparation; treatment
Prior art date: 2006-08-15

Application number

BRPI0715893-9A2A

Other languages

English (en)

Inventor

Hamed Aissaoui

Ralf Koberstein

Christoph Boss

Markus Gude

Thierry Sifferlen

Original Assignee

Actelion Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-15

Filing date

2007-08-15

Publication date

2013-09-17

2007-08-15 Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd

2013-09-17 Publication of BRPI0715893A2 publication Critical patent/BRPI0715893A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D515/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L19/00—Compositions of rubbers not provided for in groups C08L7/00 - C08L17/00
- C08L19/006—Rubber characterised by functional groups, e.g. telechelic diene polymers
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L21/00—Compositions of unspecified rubbers
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
- C08L83/10—Block- or graft-copolymers containing polysiloxane sequences

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Polymers & Plastics (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Obesity (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Anesthesiology (AREA)
Emergency Medicine (AREA)
Gynecology & Obstetrics (AREA)

BRPI0715893-9A2A 2006-08-15 2007-08-15 composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono BRPI0715893A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IB2006052814		2006-08-15
PCT/IB2007/053244 WO2008020405A2 (en)	2006-08-15	2007-08-15	Azetidine compounds as orexin receptor antagonists

Publications (1)

Publication Number	Publication Date
BRPI0715893A2 true BRPI0715893A2 (pt)	2013-09-17

Family

ID=38988127

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0715893-9A2A BRPI0715893A2 (pt)	2006-08-15	2007-08-15	composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono

Country Status (15)

Country	Link
US (1)	US7994336B2 (pt)
EP (1)	EP2069332B1 (pt)
JP (1)	JP2010500401A (pt)
KR (1)	KR101113626B1 (pt)
CN (1)	CN101506199A (pt)
AT (1)	ATE500250T1 (pt)
AU (1)	AU2007285371A1 (pt)
BR (1)	BRPI0715893A2 (pt)
CA (1)	CA2659299A1 (pt)
DE (1)	DE602007012910D1 (pt)
ES (1)	ES2360376T3 (pt)
MX (1)	MX2009001432A (pt)
PL (1)	PL2069332T3 (pt)
RU (1)	RU2447070C2 (pt)
WO (1)	WO2008020405A2 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200823227A (en) *	2006-09-29	2008-06-01	Actelion Pharmaceuticals Ltd	3-aza-bicyclo[3.1.0]hexane derivatives
US8133901B2 (en)	2006-12-01	2012-03-13	Actelion Pharmaceuticals Ltd.	3-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitors
CL2007003827A1 (es) *	2006-12-28	2008-09-26	Actelion Pharmaceuticals Ltd	Compuestos derivados de n-(2-aza-biciclo(3.1.0)hex-3-ilmetil)amida; y su uso para prevenir o tratar la depresion, neurosis, esquizofrenia, ansiedad, adicciones, epilepsia, dolor, enfermedades cardiacas, entre otras.
CL2008000836A1 (es) *	2007-03-26	2008-11-07	Actelion Pharmaceuticals Ltd	Compuestos derivados de tiazolidina, antagonistas del receptor de orexina; composicion farmaceutica que los comprende; y su uso en el tratamiento de neurosis emocional, depresion grave, trastornos psicoticos, alzheimer, parkinson, dolor, entre otras.
KR101480279B1 (ko)	2007-05-23	2015-01-09	머크 샤프 앤드 돔 코포레이션	피리딜 피페리딘 오렉신 수용체 길항제
PL2164847T3 (pl) *	2007-07-03	2012-02-29	Actelion Pharmaceuticals Ltd	Związki 3-azabicyklo[3.3.0]oktanowe
EP2025674A1 (de)	2007-08-15	2009-02-18	sanofi-aventis	Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JP2010540429A (ja) *	2007-09-24	2010-12-24	アクテリオンファーマシューティカルズリミテッド	オレキシン受容体拮抗薬としてのピロリジン類及びピペリジン類
WO2009104155A1 (en) *	2008-02-21	2009-08-27	Actelion Pharmaceuticals Ltd	2-aza-bicyclo[2.2.1]heptane derivatives
CA2722347A1 (en) *	2008-04-30	2009-11-05	Actelion Pharmaceuticals Ltd	Piperidine and pyrrolidine compounds
EP2161266A1 (en)	2008-08-22	2010-03-10	EVOTEC Neurosciences GmbH	Benzofuran derivatives as orexin receptor antagonists
CA2739344A1 (en) *	2008-10-14	2010-04-22	Actelion Pharmaceuticals Ltd	Phenethylamide derivatives and their heterocyclic analogues
US8796297B2 (en)	2009-06-30	2014-08-05	Abbvie Inc.	4-substituted-2-amino-pyrimidine derivatives
US8653263B2 (en)	2009-10-23	2014-02-18	Janssen Pharmaceutica	Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
WO2011138266A1 (en)	2010-05-03	2011-11-10	Evotec Ag	Indolizine and imidazopyridine derivatives as orexin receptor antagonists
WO2011138265A2 (en)	2010-05-03	2011-11-10	Evotec Ag	Indole and indazole derivatives as orexin receptor antagonists
WO2012063207A1 (en) *	2010-11-10	2012-05-18	Actelion Pharmaceuticals Ltd	Lactam derivatives useful as orexin receptor antagonists
AR088352A1 (es)	2011-10-19	2014-05-28	Merck Sharp & Dohme	Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
US9440982B2 (en)	2012-02-07	2016-09-13	Eolas Therapeutics, Inc.	Substituted prolines/piperidines as orexin receptor antagonists
RU2014136339A (ru)	2012-02-07	2016-03-27	Иолас Терапьютикс, Инк.	Замещенные пролины/пиперидины как антагонисты орексиновых рецепторов
TWI510481B (zh)	2012-06-04	2015-12-01	Actelion Pharmaceuticals Ltd	苯并咪唑脯胺酸衍生物
AU2013292529A1 (en) *	2012-07-18	2015-02-12	Marvin J. Miller	5,5-heteroaromatic anti-infective compounds
EA201500399A1 (ru)	2012-10-10	2015-09-30	Актелион Фармасьютиклз Лтд.	Антагонисты рецептора орексина, которые представляют собой производные [орто-би-(гетеро)арил]-[2-(мета-би-(гетеро)арил)пирролидин-1-ил]метанона
EP2970241A1 (en)	2013-03-12	2016-01-20	Actelion Pharmaceuticals Ltd.	Azetidine amide derivatives as orexin receptor antagonists
UA119151C2 (uk)	2013-12-03	2019-05-10	Ідорсія Фармасьютікалз Лтд	КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
ES2651475T3 (es)	2013-12-03	2018-01-26	Idorsia Pharmaceuticals Ltd	Forma cristalina de (S)-(2-(6-cloro-7-metil-1H-benzo[d]imidazol-2-il)-2-metilpirrolidin-1-il)(5-metoxi-2-(2H-1,2,3-triazol-2-il)fenil)metanona y su uso como antagonistas del receptor de orexina
AU2014358766B2 (en)	2013-12-04	2019-01-17	Idorsia Pharmaceuticals Ltd	Use of benzimidazole-proline derivatives
AR101558A1 (es)	2014-08-13	2016-12-28	Eolas Therapeutics Inc	Difluoropirrolidinas como moduladores del receptor de orexina
RS63471B1 (sr)	2016-02-12	2022-08-31	Astrazeneca Ab	Halo-supstituisani piperidini kao modulatori receptora oreksina
NZ785827A (en)	2016-03-10	2025-05-02	Janssen Pharmaceutica Nv	Methods of treating depression using orexin-2 receptor antagonists
US20190151304A1 (en)	2016-05-10	2019-05-23	Inserm (Institut National De La Santé Et De La Rechercjae Médicale	Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory
HRP20211304T1 (hr)	2017-05-03	2021-11-12	Idorsia Pharmaceuticals Ltd	Pripravljanje derivata 2-([1,2,3]triazol-2-il)-benzojeve kiseline
US11319286B2 (en)	2017-08-03	2022-05-03	Takeda Pharmaceutical Company Limited	Heterocyclic compound and application thereof
WO2020007964A1 (en)	2018-07-05	2020-01-09	Idorsia Pharmaceuticals Ltd	2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives
WO2020007977A1 (en)	2018-07-06	2020-01-09	Idorsia Pharmaceuticals Ltd	7-trifluoromethyl-[1,4]diazepan derivatives
WO2020099511A1 (en)	2018-11-14	2020-05-22	Idorsia Pharmaceuticals Ltd	Benzimidazole-2-methyl-morpholine derivatives
TW202400149A (zh)	2022-05-13	2024-01-01	瑞士商愛杜西亞製藥有限公司	經噻唑并芳基-甲基取代之環狀肼-n-甲醯胺衍生物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH621126A5 (pt)	1974-02-07	1981-01-15	Plantex Ltd
US4956372A (en)	1987-10-02	1990-09-11	Kyorin Pharmaceutical Co., Ltd.	Cyclic anthranilic acid derivatives and process for their preparation
GB9303340D0 (en)	1993-02-19	1993-04-07	Smithkline Beecham Plc	Pharmaceuticals
EP0757692A1 (en)	1994-04-29	1997-02-12	PHARMACIA & UPJOHN COMPANY	Methanol derivatives for treatment of retroviral infections especially hiv infections
AU3386700A (en)	1999-03-02	2000-09-21	Merck & Co., Inc.	3-thienyl and 3-furanyl pyrrolidine modulators of chemokine receptor activity
EP1289955B1 (en) *	2000-06-16	2005-04-13	Smithkline Beecham Plc	Piperidines for use as orexin receptor antagonists
EP1353905B1 (en)	2000-11-20	2007-01-10	Scios Inc.	Piperidine/piperazine-type inhibitors of p38 kinase
TW591020B (en)	2001-06-20	2004-06-11	Wyeth Corp	6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
AU2003262516A1 (en) *	2002-09-18	2004-04-08	Glaxo Group Limited	N-aroyl cyclic amines as orexin receptor antagonists
GB0305553D0 (en)	2003-03-11	2003-04-16	Glaxo Group Ltd	Compounds
TW200508221A (en) *	2003-06-13	2005-03-01	Astrazeneca Ab	New azetidine compounds
US7939534B2 (en) *	2006-08-01	2011-05-10	Cytokinetics, Inc.	Certain chemical entities, compositions, and methods

2007
- 2007-08-15 RU RU2009109150/04A patent/RU2447070C2/ru not_active IP Right Cessation
- 2007-08-15 AT AT07826034T patent/ATE500250T1/de active
- 2007-08-15 CN CNA2007800303591A patent/CN101506199A/zh active Pending
- 2007-08-15 US US12/377,349 patent/US7994336B2/en not_active Expired - Fee Related
- 2007-08-15 DE DE602007012910T patent/DE602007012910D1/de active Active
- 2007-08-15 JP JP2009524298A patent/JP2010500401A/ja active Pending
- 2007-08-15 EP EP07826034A patent/EP2069332B1/en not_active Not-in-force
- 2007-08-15 BR BRPI0715893-9A2A patent/BRPI0715893A2/pt not_active IP Right Cessation
- 2007-08-15 AU AU2007285371A patent/AU2007285371A1/en not_active Abandoned
- 2007-08-15 PL PL07826034T patent/PL2069332T3/pl unknown
- 2007-08-15 KR KR1020097005339A patent/KR101113626B1/ko not_active Expired - Fee Related
- 2007-08-15 CA CA002659299A patent/CA2659299A1/en not_active Abandoned
- 2007-08-15 MX MX2009001432A patent/MX2009001432A/es active IP Right Grant
- 2007-08-15 WO PCT/IB2007/053244 patent/WO2008020405A2/en active Application Filing
- 2007-08-15 ES ES07826034T patent/ES2360376T3/es active Active

Also Published As

Publication number	Publication date
ES2360376T3 (es)	2011-06-03
KR101113626B1 (ko)	2012-02-17
WO2008020405A2 (en)	2008-02-21
MX2009001432A (es)	2009-02-17
US7994336B2 (en)	2011-08-09
DE602007012910D1 (de)	2011-04-14
PL2069332T3 (pl)	2011-07-29
KR20090040916A (ko)	2009-04-27
RU2447070C2 (ru)	2012-04-10
EP2069332A2 (en)	2009-06-17
RU2009109150A (ru)	2010-09-27
AU2007285371A1 (en)	2008-02-21
ATE500250T1 (de)	2011-03-15
EP2069332B1 (en)	2011-03-02
US20100222600A1 (en)	2010-09-02
JP2010500401A (ja)	2010-01-07
WO2008020405A3 (en)	2008-07-17
CN101506199A (zh)	2009-08-12
CA2659299A1 (en)	2008-02-21

Publication	Publication Date	Title
BRPI0715893A2 (pt)	2013-09-17	composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono
ATE493386T1 (de)	2011-01-15	Trans-3-aza-bicyclo-ä3.1.0ü-hexan-derivate
TW200833328A (en)	2008-08-16	2-aza-bicyclo[3.1.0]hexane derivatives
MX2009005363A (es)	2009-06-05	Pirimidinas y su uso como antagonistas del receptor cxcr2.
ATE524466T1 (de)	2011-09-15	3-azabicycloä3.3.0üoktanverbindungen
MX2010008993A (es)	2010-09-07	Derivados de 2-aza-biciclo-[2.2.1]heptano.
ATE483707T1 (de)	2010-10-15	2-cyclopropylthiazolderivate
ATE482210T1 (de)	2010-10-15	Oxadiazolderivate als s1p1-rezeptor-agonisten
WO2007108936A3 (en)	2007-11-01	N-substituted-azacyclylamines as histamine-3 antagonists
BRPI0910182B8 (pt)	2021-05-25	composto de fórmula (i), composição farmacêutica e uso de um composto
BR122013025375B8 (pt)	2021-05-25	compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas
MX2009009690A (es)	2009-12-14	Derivados de tiazolidina como antagonistas del receptor de orexina.
WO2008045371A3 (en)	2008-06-19	N-substituted-azacyclylamines as histamine-3 antagonists
WO2007136668A3 (en)	2008-01-24	N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
WO2008007211A8 (en)	2009-03-26	Substituted n-bicyclicalkyl bicyclic carboxyamide compounds
BRPI0811842A2 (pt)	2014-11-18	Composto, composição farmacêutica, uso de um composto, e, métodos para aumentar a qualidade do sono em um paciente mamífero, para tratar a insônia em um paciente mamífero, e para tratar ou controlar a obesidade em um paciente mamífero
WO2009016564A3 (en)	2009-03-26	2-aza-bicyclo[3.3.0]octane derivatives
DE602007012072D1 (de)	2011-03-03	Orantagonisten
MX2010001575A (es)	2010-03-15	Derivados de 1,2-diamido-etileno como antagonistas de orexina.
DE602006006712D1 (de)	2009-06-18	Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
UA92670C2 (ru)	2010-11-25	Пиразолиновые соединения и их фармацевтическое применение, композиция на их основе
MX2010002760A (es)	2010-04-01	Derivados de isoquinolinilo e isoindolinilo como antagonistas de la histamina-3.
IL206359A0 (en)	2010-12-30	Sulfonamides as orexin antagonists
DE602005023197D1 (de)	2010-10-07	-muscarinrezeptors
WO2010123959A3 (en)	2011-02-17	2,5-disubstituted arylsulfonamide ccr3 antagonists

Legal Events

Date	Code	Title	Description
2014-08-26	B08L	Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]	Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 6A E 7A ANUIDADES.
2020-11-10	B08I	Publication cancelled [chapter 8.9 patent gazette]	Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.
2020-11-17	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 6A, 7A, 8A, 9A, 10A, 11A, 12A E 13A ANUIDADES.
2021-03-09	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.